Regulatory guidance is content typically published by national (or European) government agencies e.g. FDA, NICE, IQWiG, European Medicines Agency EMA).  It’s a fairly new category of evidence, released in the new design, and most of the content relates to pharmaceutical drugs.  It works like every other category, you search and then click on the ‘Regulatory Guidance’ link in the ‘Refine’ box on the right hand side of the results page, see the two images below.

This is an incredibly powerful feature.  Searching sites like the FDA and EMA can be challenging to say the least and Trip makes it easy.  This content is really useful, featuring additional content not included in journal articles (e.g. see this Brexpiprazole review) and has typically been rigorously assessed by the relevant agency.

Why not try it now with these two canned searches (just click on the link):

Trip – making evidence easy

Reg guidance 1

Reg guidance

Advertisements